Eli Lilly Wins $312.5 Million US Army Contract to Supply COVID-19 Drug Candidate LY-CoV555 - (Fidelity via NewsPoints Desk)

  • Eli Lilly secured a contract valued at $312.5 million from the US Army to provide its drug candidate for COVID-19 infection LY-CoV555, as reported Fidelity on Friday.

  • Work under the contract is expected to be completed by next June 30.

To read more NewsPoints articles, click here.